Drug maker Plethico Pharmaceuticals today said it will split its stock in the ratio of 1:10.


</p><tr><td><p class='TableClas'></p><P class='TableClas'><DIV CLASS=rightDiv><script language="JavaScript">
		google_ad_client = 'businessstandard';
		//google_ad_client = 'ca-businessstandard_js';
		google_ad_width = 200;
		google_ad_height = 200;
		google_ad_format = "200x200_as";
		google_ad_type = "text";
		google_ad_channel = "";
		//google_color_border = "FFFFFF";
		google_color_border = "F7F7F7";
		//google_color_bg = "FFFFFF";
		google_color_bg = "ffffff";
		//google_color_link = "639ACE";
		google_color_link = "0253B7";
		google_color_text = "000000";
		google_color_url = "D63431";
		//google_skip = adsenseSkip;
		</script> 
		<script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
		</script> </DIV><p class='TableClas'>The board has approved the subdivision of equity shares of face value of Rs 10 into 10 shares of face value of Re 1, the company said in a filing to the Bombay Stock Exchange.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P>
</p><p class='TableClas'>Further, the board has declared a dividend of 25 per cent, at the rate of Rs 2.50 on shares of face value Rs 10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shares of Plethico Pharma closed at Rs 411.40, up 3.92 per cent on the BSE.</P></p><p class='TableClas'></p></table>


Plethico board approves 1:10 stock split

More From This Section

Posco land acquisition resumes amid protests

Diageo to buy half of Mallya's South Africa beer biz

Average money spent for new players dips

'IndiGo did not comply with AAC guidelines'

Explore News